Oncimmune’s Chief Executive Officer, Martin Gouldstone, and Finance Director, Martin Hudson, provide an investor update following the announcement of the company’s interim results.
Investor Update
22 May 2024
22 May 2024
Oncimmune’s Chief Executive Officer, Martin Gouldstone, and Finance Director, Martin Hudson, provide an investor update following the announcement of the company’s interim results.